1 in order to create a chemical fit distantly reminiscent of rifampicin (2) . Compounds 1 are obtained by treatment of 3-hydrazinomethylrifamycin SV2) with a suitable chloroformiminium chloride (in tetrahydrofuran, 0°~ +20°C)1). Relevant data are reported in Table 1 Table 2 . Plasma levels were determined in CD1 Cobs albino mice.
Groups of 5 animals were treated orally with 10 mg/kg of the substances diluted in phosphate buffer pH 7 + 5 % of dimethylformamide (0.1 ml/10 g body weight). After various times (between 1 and 36 hours) 3 mice/group were sacrificed, and plasma was collected for bioassay on Micrococcus luteus ATCC 9341 by the agar diffusion technique. Half-life values, peak concentrations (Cmax) and time of peak (tmax) are reported in Table 3. 3-(Piperidinomethylazinomethyl)rifamycin SV (1a) 5 g of 3-formylrifamycin SV were dissolved in 250 ml of THE and added dropwise to a solution of 0.35 ml hydrazine hydrate in 50 ml of THE during 15 minutes under stirring at -20°C.
The absence of the starting material was checked by TLC and 2 ml of triethylamine were added keeping the temperature at -20°C.
5 g of chloropiperidyl formiminium chloride were added portionwise and the mixture warmed gently to room temperature under stirring. EtOAc (350 ml) were added and the resulting solution washed with H2O. After drying over anhydrous sodium sulfate, the solvent was evaporated and the crude product was crystallized from MeOH and then from acetone. 2.3 g of la were obtained.
Anal Calcd for C44H58N4O12 : C 63.02, H 7.02, N 6.68. Found: C 62.59, H 7.13, N 6.61.
